Tangential Flow Filtration Market Future Prospects
The tangential flow filtration market revenue stood at USD 1,981.9 million in 2024, and it is expected to advance at a CAGR of 10.8% during 2024–2030, reaching USD 3,667.2 million by 2030.
The growth in the biopharmaceutical sector, particularly the development of biosimilars and biologics manufacturing, increased investment in research and development by industry participants, and advantages of tangential flow filtration over normal flow filtration, are the key factors driving the market growth. Biotechnology companies have been largely investing in research and development while obtaining patents for the same. In the last 20 years, global research and development spending in the sector has increased by over 12%.
The TFF market witnessed a positive impact of the COVID-19 pandemic, as TFF systems have been extensively used in the production of vaccines. Moreover, companies have been expanding their capacities to manufacture COVID-19 vaccines, which lead to the increasing demand for these systems. For instance, in January 2022, Ardena announced the plans to expand its production capacity for COVID-19 vaccines, which will incorporate additional chromatography and tangential flow filtration.